Production (Stage)
Envoy Medical, Inc.
COCH
$1.63
-$0.035-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.89% | 30.50% | 42.27% | 65.31% | 15.99% |
| Total Depreciation and Amortization | 42.86% | 30.08% | 55.86% | 47.12% | 57.30% |
| Total Amortization of Deferred Charges | 48.39% | 118.77% | -- | -- | -- |
| Total Other Non-Cash Items | -85.92% | -82.69% | -91.27% | -119.09% | -68.98% |
| Change in Net Operating Assets | 150.60% | 33.77% | -202.16% | -400.00% | -508.85% |
| Cash from Operations | 19.53% | -3.52% | -193.68% | -72.60% | -99.91% |
| Capital Expenditure | -332.02% | -540.52% | -787.28% | -135.29% | 18.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -332.02% | -540.52% | -787.28% | -425.13% | 18.80% |
| Total Debt Issued | 81.82% | 100.00% | 25.00% | -12.50% | 10.00% |
| Total Debt Repaid | -40.12% | -108.35% | -- | -- | -- |
| Issuance of Common Stock | -75.78% | 1,842.20% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.53% | -84.53% | -100.00% | 12,656.52% | 12,656.52% |
| Cash from Financing | -28.00% | -6.30% | -45.13% | 91.93% | 134.92% |
| Foreign Exchange rate Adjustments | 140.00% | -66.67% | 28.57% | 28.57% | 37.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -90.42% | -68.65% | -176.50% | 42,050.00% | 76,720.00% |